Brand Name: BIZENGRI. Generic Name: (zenocutuzumab-zbco). It is used to treat non–small cell lung cancer (NSCLC) or pancreatic adenocarcinoma.
BIZENGRI is a prescription medicine used to treat adults with non–small cell lung cancer (NSCLC) or pancreatic adenocarcinoma.
Brand Name: | BIZENGRI |
Generic Name: | zenocutuzumab-zbco |
Strength: | • |
Manufacturer: | |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “BIZENGRI (zenocutuzumab-zbco) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.